STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Management ChangeApr 10, 2026, 04:06 PM

Immunic CEO Daniel Vitt to Receive $670K Retention Bonus

AI Summary

Immunic, Inc. has entered into a Retention Bonus Agreement with its Chief Executive Officer, Daniel Vitt, for $670,000. This agreement is in connection with the company's search for a new CEO and Mr. Vitt's potential transition to a C-Suite role focused on strengthening scientific strategy. The bonus is payable upon his continued employment 91 days after a new CEO is hired, or earlier under specific termination conditions.

Key Highlights

  • CEO Daniel Vitt to receive a $670,000 retention bonus.
  • Bonus is tied to the company's search for a new Chief Executive Officer.
  • Mr. Vitt may transition to a C-Suite role focused on scientific strategy.
  • Bonus payable 91 days after a new CEO is hired, or upon certain terminations.
IMUX
Biotechnology: Pharmaceutical Preparations
IMMUNIC, INC.

Price Impact